Global Nasal Spray Vaccine Market – Industry Trends and Forecast to 2029

Global Nasal Spray Vaccine Market, By Type (Child, Adult), Container Design (Pressurized Container, Pump Bottles), Capacity (5ml-10ml, 11ml-20ml, 21ml-30ml, Above 30ml), Material (Polyethylene (PE), Polypropylene (PP), Polyethylene Terephthalate (PET), Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Market Analysis and Size                              

Nasal spray vaccine is simply a vaccine that is administered through the nose and is most usually used to provide vaccines for diseases such as the common cold, viral infection, and influenza. Nasal sprays have been shown to effectively administer immunization to patients via the nasal cavity. Nasal spray has been developed by makers of vaccine packaging goods all over the world for the storage and transportation of various medications and vaccines. The market appeal of nasal spray as a preferred packaging for other medicinal treatments is expanding as various over-the-counter pharmaceuticals and ophthalmic antibiotics gain worldwide acceptability.

Data Bridge Market Research analyses that the nasal spray vaccine market was valued at USD 122.287 million in 2021 and is expected to reach USD 250.91 million by 2029, registering a CAGR of 9.40% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Nasal spray vaccines are a type of vaccine administered by the nose and are commonly used to treat influenza. The nasal spray vaccine aids in the treatment of viral illnesses. It targets the lungs and other organs directly, causing breathing problems in the patient. Additionally, it can aid in the avoidance of becoming ill and infecting others. Generally, nasal spray vaccines are manufactured from weakened flu viruses. As a result of its advantages and ability to prevent infections, the nasal spray vaccine is expected to see significant market growth.

Nasal Spray Vaccine Market Dynamics

Drivers

• Rise in the prevalence of respiratory infections

The surging prevalence of respiratory infections including Streptococcus, Enterobacteriaceae, and viral such as Coronavirus, Haemophilus influenza, Adenovirus and others is a major factor driving the nasal spray vaccine market's growth rate during the forecast period of 2022-2029. According to the Forum of International Respiratory Societies, lower respiratory tract infection and pneumonia affect 4 million people each year. According to the World Health Organization (WHO), influenza has resulted in approximately 3 to 5 million hospitalizations and 0.2 million fatalities.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of nasal spray vaccine market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the nasal spray vaccine market. Additionally, sedentary lifestyle of people and surging geriatric population will result in the expansion of nasal spray vaccine market. Along with this, favourable reimbursement policies will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the nasal spray vaccine market growth.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the nasal spray vaccine market during the forecast period.

Restraints/Challenges

On the other hand, high-cost factor and restricted delivery volume will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and limited efficacy and altered drug permeability because of mucociliary activities, poor antigen retention will challenge the nasal spray vaccine market. Additionally, limited compatible adjuvants and side effects of vaccine such as pain and mild fever will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This nasal spray vaccine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nasal spray vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Nasal spray vaccine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Nasal Spray Vaccine Market

The COVID-19 outbreak and subsequent lockdown in numerous countries around the world had a huge impact on the financial status of enterprises in all sectors. The private healthcare sector is one of the areas where the pandemic had a significant impact. The coronavirus pandemic had a significant influence on medicine development, production, supply, and the businesses of different healthcare corporations around the world. The outbreak has resulted in the shutdown of industrial establishments, with the exception of those that manufacture critical commodities, and disruptions in product supply chains. As a result, the COVID-19 outbreak had impacted the economy by directly influencing production and demand, causing distribution channel disruptions, and having a financial impact on firms and financial markets.

On the brighter side, there was a high need for nasal spray vaccine during the pandemic due to the increased COVID-19 burden and respiratory infections, which further fuelled the market’s growth rate. The number of research and development activities on nasal spray vaccine for the treatment of COVID-19 is also increased. Nasal vaccines may be the most effective strategy to prevent infections over time because they protect the virus where it is most needed: the mucosal linings of the airways, where the coronavirus initially arrives.

Recent Development

• In February 2022, Glenmark Pharma had announced the launch of its nitric oxide nasal spray (NONS) named FabiSpray. It is used to treat COVID-19 for adult patients who have high risk of progression of the disease. Its purpose is to kill the COVID-19 virus in the upper respiratory tract. It has antimicrobial characteristics and has a direct virucidal effect on the SARS-CoV-2 virus. When sprayed on the nasal mucosa, NONS serves as a physical and chemical barrier, stopping the virus from incubating and spreading to the lungs.

Global Nasal Spray Vaccine Market Scope

The nasal spray vaccine market is segmented on the basis of type, container design, capacity, material, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Container Design

• Pressurized Container
• Pump Bottles

Capacity

• 5ml-10ml
• 11ml-20ml
• 21ml-30ml
• Above 30ml

Material

• Polyethylene (PE)
• Polypropylene (PP)
• Polyethylene Terephthalate (PET)
• Others

Type

• Child
• Adult

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Nasal Spray Vaccine Market Regional Analysis/Insights

The nasal spray vaccine market is analysed and market size insights and trends are provided by country, type, container design, capacity, material, end-users and distribution channel as referenced above.

The countries covered in the nasal spray vaccine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the nasal spray vaccine market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players, and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, increasing research and development activities will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022-2029 due to technological advancement in this region. Also, the development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Nasal Spray Vaccine Market Share Analysis

The nasal spray vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nasal spray vaccine market.

Some of the major players operating in the nasal spray vaccine market are:

• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Merck & Co., Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Allergan (Ireland)
• Dr. Reddy’s Laboratories Ltd. (India)
• Cipla Inc. (US)
• Assertio Therapeutics, Inc. (US)
• Bayer AG (Germany)
• Jay-Pharma (India)
• St. Renatus (US)
• Ultratech India Limited (India)
• Leeford Healthcare Limited (India)
• Catalent, Inc (US)